Qiagen N.V. – QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships

Two new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials with significant expansion of MRD capabilities – especially …

Korea Innovation QuickFire Challenge: Targeting Neuroscience

Overview Despite significant advances in understanding and treating nervous system disorders, millions of people worldwide continue to live with neurodegenerative …

Unlocking Urologic Oncology Innovation QuickFire Challenge

Overview As our population ages, the incidence of bladder and prostate cancers (commonly known as Genitourinary or GU cancers) continues …

Arab Health event and congress contributed US$269.7 million to Dubai’s economy during 2024 edition

Tourism and hospitality key beneficiaries of Arab Health as accommodation spend during the 2024 event totalled more than US$56.2 million …

BIO-OSCAR SOC trial examines standard of care in PAD treatment

Koen Deloose presents BIO-OSCAR SOC data at PVI 2024 BIOTRONIK has concluded the BIO-OSCAR SOC, a prospective, multicenter, observational trial …

New Emerson Solution Reduces Energy Costs, Carbon Emissions for Manufacturers 

Emerson’s new Energy Manager solution helps manufacturers cut energy costs and carbon emissions by up to 30%, offering real-time electricity …

Dr. Christine Munz becomes CEO at Eppendorf

> Dr. Christine Munz appointed as CEO > Dr. Wilhelm Plüster completes term in office as planned Hamburg, August 30, …

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better …